Most Read Articles
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Roshini Claire Anthony, 5 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

6 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.

LAI aripiprazole: An optimal treatment option for schizophrenia

11 Apr 2019
Schizophrenia is a highly debilitating mental condition, affecting more than 21 million people globally. It is characterized by delusions, hallucinations, and other symptoms which impair social and occupational functions.1 Schizophrenia imposes substantial health, social and economic burden. In Malaysia,the total costs of schizophrenia were estimated at USD100 million in 2013; of which 72% was attributed to indirect cost or productivity loss, followed by direct medical cost (26%).2 The enormous economic burden of schizophrenia is suggestive of an inadequate provision of healthcare services to these patients. Alarmingly, treatment nonadherence is associated with substantial direct medical costs that extend beyond the cost of rehospitalization to other outpatient services and medication costs,3,4 highlighting the need to improve treatment adherence to antipsychotic medication.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Roshini Claire Anthony, 5 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

6 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.